Rights and permissions
About this article
Cite this article
Additional reimbursement for fidaxomicin. Pharmacoecon. Outcomes News 660, 10 (2012). https://doi.org/10.2165/00151234-201206600-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206600-00027